학술논문

Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): Analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment)
Document Type
Article
Source
In: Anti-Cancer Drugs. (Anti-Cancer Drugs, 2014, 25(2):212-218)
Subject
Language
English
ISSN
09594973
14735741